Earkart Limited
Earkart an Indian tech-driven hearing healthcare company dedicated to making advanced audiology services and hearing aids more accessible, affordable, and transparent. Listed on the BSE SME platform, it operates across India and neighboring countries, specializing in both manufacturing and distributing modern digital hearing solutions
- Market Cap ₹ 220 Cr.
- Current Price ₹ 160
- High / Low ₹ 266 / 104
- Stock P/E 44.6
- Book Value ₹ 46.8
- Dividend Yield 0.00 %
- ROCE 17.5 %
- ROE 11.7 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Working capital days have increased from 161 days to 237 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Equipment & Supplies Medical Equipment & Supplies
Part of BSE SME IPO
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| 5.66 | 28.92 | 31.75 | 43.11 | 54.04 | |
| 5.52 | 27.29 | 28.17 | 33.32 | 45.69 | |
| Operating Profit | 0.14 | 1.63 | 3.58 | 9.79 | 8.35 |
| OPM % | 2.47% | 5.64% | 11.28% | 22.71% | 15.45% |
| 0.04 | 0.05 | 0.21 | 0.09 | 0.11 | |
| Interest | 0.01 | 0.08 | 0.36 | 0.44 | 0.54 |
| Depreciation | 0.06 | 0.15 | 0.19 | 0.42 | 0.66 |
| Profit before tax | 0.11 | 1.45 | 3.24 | 9.02 | 7.26 |
| Tax % | 0.00% | 9.66% | 5.86% | 23.61% | 31.96% |
| 0.11 | 1.31 | 3.06 | 6.88 | 4.93 | |
| EPS in Rs | 22.00 | 262.00 | 612.00 | 6.59 | 3.58 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 23% |
| TTM: | 25% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 56% |
| TTM: | -28% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 21% |
| 3 Years: | 22% |
| Last Year: | 12% |
Balance Sheet
Figures in Rs. Crores
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Equity Capital | 0.05 | 0.05 | 0.05 | 10.44 | 13.75 |
| Reserves | 4.72 | 6.49 | 12.97 | 9.48 | 50.59 |
| 0.27 | 1.23 | 4.02 | 4.96 | 0.00 | |
| 0.91 | 6.96 | 2.21 | 5.41 | 5.15 | |
| Total Liabilities | 5.95 | 14.73 | 19.25 | 30.29 | 69.49 |
| 0.22 | 0.25 | 1.06 | 1.17 | 5.88 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 1.46 | 0.10 | 0.19 | 0.83 | 0.15 |
| 4.27 | 14.38 | 18.00 | 28.29 | 63.46 | |
| Total Assets | 5.95 | 14.73 | 19.25 | 30.29 | 69.49 |
Cash Flows
Figures in Rs. Crores
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| -2.83 | -0.30 | -1.00 | 0.71 | -12.56 | |
| -1.78 | 0.40 | -1.29 | -1.32 | -5.18 | |
| 4.68 | 0.41 | 3.08 | -0.41 | 39.06 | |
| Net Cash Flow | 0.07 | 0.51 | 0.80 | -1.01 | 21.32 |
| Free Cash Flow | -3.11 | -0.48 | -1.99 | 0.18 | -17.93 |
| CFO/OP | -2,007% | -17% | -22% | 30% | -122% |
Ratios
Figures in Rs. Crores
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Debtor Days | 104.47 | 59.32 | 72.89 | 157.23 | 142.31 |
| Inventory Days | 138.26 | 100.90 | 113.12 | 95.52 | 121.11 |
| Days Payable | 92.17 | 107.33 | 19.28 | 44.04 | 19.96 |
| Cash Conversion Cycle | 150.56 | 52.89 | 166.73 | 208.70 | 243.46 |
| Working Capital Days | 192.17 | 60.83 | 108.06 | 139.02 | 237.21 |
| ROCE % | 23.89% | 29.02% | 45.13% | 17.48% |
Insights
In beta| Dec 2021 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Government Revenue Share % |
|
||
| Cities Presence cities |
|||
| Dealer Partners dealers |
|||
| Hearing Aid Production Capacity units/year |
|||
| Hearing Aid Production Volume units/year |
|||
| Manufacturing & Office Area sq ft |
|||
| SIS (Shop-in-Shop) Clinics clinics |
|||
Extracted by Screener AI
Documents
Announcements
-
Newspaper Advertisement- Public Notice To The Members For The 5Th Annual General Meeting Of The Company Scheduled To Be Held On Wednesday, 15 July 2026 Through Video Conferencing(''''VC'''')/ Other Audio-Visual Means(''''OAVM'''')
30 Jun - Public notice for 5th AGM on 15 July 2026 at 3:00 p.m. via VC/OAVM.
-
Announcement under Regulation 30 (LODR)-Investor Presentation
27 Jun - Submission of Investor Presentation for the F.Y. 2026 under Regulation 30 (LODR)
- Intimation Of Date Of 5Th Annual General Meeting (AGM) Of The Company For The FY 2025-26 23 Jun
-
Announcement under Regulation 30 (LODR)-Acquisition
22 Jun - Earkart Health Limited incorporated in UK on 08 June 2026; Earkart holds 65% stake.
-
Announcement under Regulation 30 (LODR)-Acquisition
30 May - Earkart approved two WOS incorporations: pharma and healthcare, with Rs1 lakh initial capital each.
Annual reports
No data available.
Concalls
-
Jun 2026TranscriptAI SummaryPPT
-
Jan 2026TranscriptPPTREC
-
Dec 2025Transcript PPT
Business Profile[1]
Earkart manufactures and distributes modern hearing aids (BTE & RIC) and accessories, trades third-party hearing aids and parts, and also supplies mobility aids (foldable walkers) and educational/therapy kits (MSIED and TLM) for children with disabilities.